Live Breaking News & Updates on Mikhail Kalinichev

Stay updated with breaking news from Mikhail kalinichev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological. ....

United States , Mikhail Kalinichev , Tim Dyer , Mike Sinclair , Swiss Exchange , Janssen Pharmaceuticals Inc , Translational Science , Addex Therapeutics , Conference Call , Participant Dial In , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,

Addex Therapeutics to Release Q1 2024 Financial Results and

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio. ....

United States , Mikhail Kalinichev , Mike Sinclair , Tim Dyer , Swiss Exchange , Janssen Pharmaceuticals Inc , Translational Science , Addex Therapeutics , Conference Call , Participant Dial In , American Depositary Shares ,

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Tim Dyer , Mike Sinclair , Mikhail Kalinichev , Swiss Exchange , Janssen Pharmaceuticals Inc , Release Full Year , Host Conference Call , Addex Therapeutics , Translational Science , Conference Call , Participant Dial In , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,

Addex and Perceptive Launch Neurosterix with $63 Million to

Addex receives CHF5M and 20% share of Neurosterix Perceptive Advisors leads $63M investment into Neurosterix Addex contributes portfolio of. ....

New York , United States , Mikhail Kalinichev , Tim Dyer , Fred Callori , Robert Lutjens , Jean Philippe Rocher , Mike Sinclair , Addex Neurosterix , Swiss Exchange , Perceptive Life Sciences Fund , Perceptive Xontogeny Venture Fund , Janssen Pharmaceuticals Inc , Hoc Announcement Pursuant , Perceptive Advisors , Acorn Bioventures , Janssen Pharmaceuticals , Managing Director , Addex Executive , Addex Executive Management , Translational Science , Executive Management , Perceptive Xontogeny Venture Funds , Perceptive Advisor , American Depositary Shares , Swiss Stock Exchange Adxn ,

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Addex receives CHF5M and 20% share of Neurosterix Perceptive Advisors leads $63M investment into Neurosterix Addex contributes portfolio of preclinical neuroscience assets and. ....

United States , New York , Addex Neurosterix , Fred Callori , Jean Philippe Rocher , Mike Sinclair , Robert Lutjens , Tim Dyer , Mikhail Kalinichev , Perceptive Life Sciences Fund , Janssen Pharmaceuticals Inc , Swiss Exchange , Perceptive Xontogeny Venture Fund , Hoc Announcement Pursuant , Perceptive Advisors , Acorn Bioventures , Janssen Pharmaceuticals , Managing Director , Addex Executive , Addex Executive Management , Translational Science , Executive Management , Perceptive Xontogeny Venture Funds , Perceptive Advisor , American Depositary Shares , Forward Looking Statements ,